Industry News
Biotechnology Industry News
Iovance sinks 50% as pivotal cell therapy data disappoint investors, but approval plan pushes ahead anyway
Iovance sinks 50% as pivotal cell therapy data disappoint investors, but approval plan pushes ahead anyway ntaylor Fri, 05/27/2022 - 04:57
ASCO: Genentech touts bispecific data for DLBCL, calling it ‘groundbreaking’ for heavily pretreated patients
ASCO: Genentech touts bispecific data for DLBCL, calling it 'groundbreaking' for heavily pretreated patients aarmstrong Thu, 05/26/2022 - 20:20
Chutes & Ladders—Alchemab CEO resigns immediately citing ‘personal reasons’
Chutes & Ladders—Alchemab CEO resigns immediately citing 'personal reasons' mbayer Thu, 05/26/2022 - 16:22
ASCO: Merck’s Keytruda combo data could spark hope for lymphoma patients who lack options
ASCO: Merck's Keytruda combo data could spark hope for lymphoma patients who lack options aarmstrong Thu, 05/26/2022 - 13:00
Avadel’s shares crumble as narcolepsy drug delayed yet again, this time on patent issue
Avadel's shares crumble as narcolepsy drug delayed yet again, this time on patent issue aarmstrong Thu, 05/26/2022 - 10:33
Vertex scoops up Catalyst’s complement pipeline for $60M cash
Vertex scoops up Catalyst’s complement pipeline for $60M cash mbayer Thu, 05/26/2022 - 09:47
With the right partner, Pfizer gains fast-track tag for previously shelved NASH drug
With the right partner, Pfizer gains fast-track tag for previously shelved NASH drug aarmstrong Thu, 05/26/2022 - 08:12
IN-ACTIV: NRx tanks as peptide fails NIH trial in severe COVID-19 patients
IN-ACTIV: NRx tanks as peptide fails NIH trial in severe COVID-19 patients ntaylor Thu, 05/26/2022 - 07:38
Biotech co-founder arrested on murder-for-hire charges
Biotech co-founder arrested on murder-for-hire charges ntaylor Thu, 05/26/2022 - 06:29
Flagship unveils ProFound Therapeutics with $75M to explore trove of new proteins
Flagship unveils ProFound Therapeutics with $75M to explore trove of new proteins mbayer Wed, 05/25/2022 - 17:03
Forte fields demand to liquidate from top shareholder who says latest asset came ‘out of thin air’
Forte fields demand to liquidate from top shareholder who says latest asset came 'out of thin air' mbayer Wed, 05/25/2022 - 11:02
BridgeBio’s CEO on staying alive, ‘motherhood and apple pie’
BridgeBio's CEO on staying alive, 'motherhood and apple pie' gmasson Wed, 05/25/2022 - 10:36
With failed COVID shot still dragging on earnings, CureVac tries to turn page to next-gen mRNA tech
With failed COVID shot still dragging on earnings, CureVac tries to turn page to next-gen mRNA tech aarmstrong Wed, 05/25/2022 - 09:45
Antios rocked as hepatitis B safety signal sparks clinical hold, termination of collaboration
Antios rocked as hepatitis B safety signal sparks clinical hold, termination of collaboration ntaylor Wed, 05/25/2022 - 07:43
Insurer plans $4B investment blitz to add lab space outside of U.S. biotech hot spots
Insurer plans $4B investment blitz to add lab space outside of U.S. biotech hot spots ntaylor Wed, 05/25/2022 - 04:22
ASCO: I-Mab, Junshi’s cancer combo performs best as a first-line NSCLC treatment, with signals for CD73 as a biomarker
ASCO: I-Mab, Junshi's cancer combo performs best as a first-line NSCLC treatment, with signals for CD73 as a biomarker mbayer Tue, 05/24/2022 - 17:40
ASCO: J&J’s multiple myeloma toolkit expands with bispecifics data
ASCO: J&J's multiple myeloma toolkit expands with bispecifics data aarmstrong Tue, 05/24/2022 - 12:28
CSL Behring gene therapy makes comeback after hold for FDA priority review
CSL Behring gene therapy makes comeback after hold for FDA priority review gmasson Tue, 05/24/2022 - 10:29
Genocea closes up shop after failing to find a buyer, delists from Nasdaq
Genocea closes up shop after failing to find a buyer, delists from Nasdaq mbayer Tue, 05/24/2022 - 10:18
Manufacturing concerns sideline INmune’s US Alzheimer’s trial
Manufacturing concerns sideline INmune's US Alzheimer's trial aarmstrong Tue, 05/24/2022 - 09:46